SHP2 allosteric inhibitor TK-453 alleviates psoriasis-like skin inflammation in mice via inhibition of IL-23/Th17 axis.
SHP2 allosteric inhibitor TK-453 alleviates psoriasis-like skin inflammation in mice via inhibition of IL-23/Th17 axis.
复制标题
SHP2 变构抑制剂 TK-453 通过抑制 IL-23/Th17 轴减轻小鼠银屑病样皮肤炎症
DOI:
10.1016/j.isci.2022.104009
复制
发表时间:
2022-04-15
期刊:
影响因子:
5.8
通讯作者:
Sun Y
中科院分区:
文献类型:
--
作者:
Wang M;Li T;Ouyang Z;Tang K;Zhu Y;Song C;Sun H;Yu B;Ji X;Sun Y
SHP2 is the first oncogenic tyrosine phosphatase encoded by PTPN11, which plays a significant regulatory role in cancer and inflammation-related diseases. Although SHP2 allosteric inhibitors have been used in phase I/II clinical trials for solid tumors, whether SHP2 inhibition alleviates psoriasis remains unclear. Here we expressed and purified SHP2 related proteins, and established an enzyme activity screening system for different conformations of SHP2. We launched an iterative medicinal chemistry program and identified the lead compound, TK-453. Importantly, TK-453 possessed stronger affinity with SHP2 than SHP099, evidenced by the cocrystal structure of SHP2/TK-453, revealing that the additional aryl-S-aryl bridge in TK-453 induces a 1.8 Å shift of the dichlorophenyl ring and an approximate 20° deviation of the pyrazine ring plane relative to SHP099. Furthermore, TK-453 significantly ameliorated imiquimod-triggered skin inflammation in mice via inhibition of the IL-23/Th17 axis, proving that SHP2 is a potential therapeutic target for psoriasis. We identify a SHP2 allosteric inhibitor TK-453, which has a stronger affinity with SHP2 Cocrystal structure shows that TK-453 occupies the allosteric pocket of SHP2 TK-453 alleviates psoriasis-like skin inflammation in mice SHP2 inhibitor provides a new strategy for the treatment of psoriasis Biological sciences; Biochemistry; Medical biochemistry
登录
查看更多内容
DOI:
10.1107/s0907444910051218
发表时间:
2011-04
期刊:
Acta crystallographica. Section D, Biological crystallography
影响因子:
--
作者:
Bunkóczi G;Read RJ
通讯作者:
Read RJ
DOI:
10.1038/nri3477
发表时间:
2013-08
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
DOI:
10.1107/s0907444904019158
发表时间:
2004-12-01
影响因子:
2.2
作者:
Emsley, P;Cowtan, K
通讯作者:
Cowtan, K
DOI:
10.1016/j.jaci.2017.07.004
发表时间:
2017-09
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
Hawkes JE;Chan TC;Krueger JG
通讯作者:
Krueger JG
DOI:
10.1107/s0907444909052925
发表时间:
2010-02
期刊:
Acta crystallographica. Section D, Biological crystallography
影响因子:
--
作者:
Adams PD;Afonine PV;Bunkóczi G;Chen VB;Davis IW;Echols N;Headd JJ;Hung LW;Kapral GJ;Grosse-Kunstleve RW;McCoy AJ;Moriarty NW;Oeffner R;Read RJ;Richardson DC;Richardson JS;Terwilliger TC;Zwart PH
通讯作者:
Zwart PH